Basic Therapeutics Concepts — clinical cases
29 questions
Sample cases
- Case 1
In a laboratory study, increasing concentrations of an agonist are applied to isolated tissue, first alone and then in the presence of a fixed concentration of a reversible competitive antagonist that binds the same receptor site. How is the agonist's concentration–response curve expected to change in the presence of the antagonist?
- A.The maximal response falls and the curve flattens, and adding more agonist cannot restore the original maximum
- B.The curve shifts to the right in parallel, and the original maximal response is still reached at higher agonist concentrations
- C.The curve shifts to the left, because less agonist is needed to occupy the remaining free receptors
- D.The curve is unchanged, because a reversible antagonist dissociates too quickly to alter the response
- Case 2
A 58-year-old man with cancer pain is receiving a full opioid receptor agonist around the clock at a dose that controls his pain well. A covering prescriber orders a single dose of an opioid that is a partial agonist at the same receptor, intending to "top up" his analgesia. What is the most likely effect of adding the partial agonist?
- A.Additive analgesia, because two drugs that activate the same receptor always produce a summed effect at that site
- B.No change in analgesia, because a partial agonist cannot bind receptors that are already occupied by a full agonist
- C.A reduced overall opioid effect, because the partial agonist displaces the full agonist and activates its receptors less
- D.A greater-than-additive response, because partial agonists sensitize the opioid receptors to the full agonist
- Case 3
A 66-year-old man has taken metoprolol 50 mg twice daily for 3 years after a myocardial infarction. He ran out 3 days ago and did not refill. He now reports palpitations and chest tightness; heart rate is 112 beats/min and blood pressure 168/96 mmHg (previously 128/78 mmHg on therapy). Which mechanism best explains this presentation?
- A.Chronic beta-blockade up-regulated beta-adrenergic receptors, so abrupt withdrawal exposed a larger receptor population to normal catecholamine levels
- B.Chronic beta-blockade down-regulated beta-adrenergic receptors, producing tolerance that persists after the drug is stopped
- C.Metoprolol accumulated in tissues and is now being released, producing direct receptor stimulation
- D.Metoprolol acts as an inverse agonist, so stopping it switches the receptors into a permanently activated state
